Literature DB >> 7532337

Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease.

J Poirier1.   

Abstract

Recent evidence indicates that apolipoprotein E (ApoE) plays a central role in the hippocampal response to injury. The co-ordinated expression of ApoE and its receptor, the ApoE/ApoB [low density lipoprotein (LDL)] receptor, appears to regulate the transport of cholesterol and phospholipids during the early and intermediate phases of the reinnervation process. During dendritic remodeling and synaptogenesis, neurons progressively repress the synthesis of cholesterol in favor of cholesterol internalization through the ApoE/LDL receptor pathway. The discovery that the epsilon 4 allele is strongly linked to both sporadic and familial late-onset Alzheimer's disease (AD) raises the possibility that a dysfunction of the lipid-transport system associated with compensatory sprouting and synaptic remodeling could be central to the AD process. The role of ApoE in the CNS is particularly important in relation to the function of the cholinergic system, which relies to a certain extent on the integrity of phospholipid homeostasis in neurons. Recent evidence suggests that the epsilon 4 allele has a direct impact on cholinergic function in AD.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7532337     DOI: 10.1016/0166-2236(94)90156-2

Source DB:  PubMed          Journal:  Trends Neurosci        ISSN: 0166-2236            Impact factor:   13.837


  106 in total

1.  Measurement of apolipoprotein E (apoE) in cerebrospinal fluid.

Authors:  C Hesse; H Larsson; P Fredman; L Minthon; N Andreasen; P Davidsson; K Blennow
Journal:  Neurochem Res       Date:  2000-04       Impact factor: 3.996

Review 2.  Recent advances in brain cholesterol dynamics: transport, domains, and Alzheimer's disease.

Authors:  W G Wood; F Schroeder; N A Avdulov; S V Chochina; U Igbavboa
Journal:  Lipids       Date:  1999-03       Impact factor: 1.880

Review 3.  The concept of FDG-PET endophenotype in Alzheimer's disease.

Authors:  Emmanuel H During; R S Osorio; F M Elahi; L Mosconi; M J de Leon
Journal:  Neurol Sci       Date:  2011-06-01       Impact factor: 3.307

4.  Apolipoprotein e genotype-dependent paradoxical short-term effects of (56)fe irradiation on the brain.

Authors:  Gwendolen E Haley; Laura Villasana; Catherine Dayger; Matthew J Davis; Jacob Raber
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-03-06       Impact factor: 7.038

5.  Enteroviruses in chronic fatigue syndrome: "now you see them, now you don't".

Authors:  M C Dalakas
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-10       Impact factor: 10.154

Review 6.  Normal genetic variation, cognition, and aging.

Authors:  P M Greenwood; Raja Parasuraman
Journal:  Behav Cogn Neurosci Rev       Date:  2003-12

Review 7.  Antioxidant strategies in neurocritical care.

Authors:  Khalid A Hanafy; Magdy H Selim
Journal:  Neurotherapeutics       Date:  2012-01       Impact factor: 7.620

8.  SorLA in glia: shared subcellular distribution patterns with caveolin-1.

Authors:  Iris K Salgado; Melissa Serrano; José O García; Namyr A Martínez; Héctor M Maldonado; Carlos A Báez-Pagán; José A Lasalde-Dominicci; Walter I Silva
Journal:  Cell Mol Neurobiol       Date:  2011-11-30       Impact factor: 5.046

9.  Sex differences in the association of the apolipoprotein E epsilon 4 allele with incidence of dementia, cognitive impairment, and decline.

Authors:  May A Beydoun; Adel Boueiz; Marwan S Abougergi; Melissa H Kitner-Triolo; Hind A Beydoun; Susan M Resnick; Richard O'Brien; Alan B Zonderman
Journal:  Neurobiol Aging       Date:  2010-07-08       Impact factor: 4.673

Review 10.  Cholesterol as a causative factor in Alzheimer's disease: a debatable hypothesis.

Authors:  W Gibson Wood; Ling Li; Walter E Müller; Gunter P Eckert
Journal:  J Neurochem       Date:  2014-01-02       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.